Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 30;12(6):727-729.
doi: 10.21037/gs-23-109. Epub 2023 May 25.

Axillary surgery in the case of limited involved axillary lymph nodes

Hans-Christian Kolberg  1 , Thorsten Kühn  2 , Maggie Banys-Paluchowski  3
Affiliations
Editorial

Axillary surgery in the case of limited involved axillary lymph nodes

Hans-Christian Kolberg et al. Gland Surg. .
No abstract available

Keywords: Breast cancer; axillary surgery; involved lymph nodes; sentinel-node biopsy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://gs.amegroups.com/article/view/10.21037/gs-23-109/coif). TK reports that he has received honoraria from Astra Zeneca, Gilead, Pfizer, Endomag, Hologic, Sirius Medical, Merit Medical, MSD, Exact Sciences, outside the submitted work. MBP reports that she has received consulting fees from Roche, Novartis, Pfizer, pfm, Eli Lilly, Onkowissen, Seagen, AstraZeneca, Eisai, Amgen, Samsung, Canon, MSD, GSK, Daiichi Sankyo, Gilead, Sirius Pintuition, Pierre Fabre and ExactSciences, honoraria from Roche, Novartis, Pfizer, pfm, Eli Lilly, Onkowissen, Seagen, AstraZeneca, Eisai, Amgen, Samsung, Canon, MSD, GSK, Daiichi Sankyo, Gilead, Sirius Pintuition, Pierre Fabre and ExactSciences, travel support from ExactSciences, Lilly, Pfizer, PierreFabre and study support from EndoMag, Mammotome, MeritMedical, Gilead, Hologic and ExactSciences, outside the submitted work. HCK has no conflicts of interest to declare.

Comment on

References

    1. Vernet-Tomás M, Argudo N, Jimenez M, et al. Accuracy of sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trial. Gland Surg 2023;12:140-51. 10.21037/gs-22-480 - DOI - PMC - PubMed
    1. Available online: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
    1. Giuliano AE, Ballman KV, McCall L, et al. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA 2017;318:918-26. 10.1001/jama.2017.11470 - DOI - PMC - PubMed
    1. Angarita S, Ye L, Rünger D, et al. Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery. Ann Surg Oncol 2021;28:2609-18. 10.1245/s10434-020-09228-5 - DOI - PubMed
    1. Morrow M, Jagsi R, McLeod MC, et al. Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer. JAMA Oncol 2018;4:1511-6. 10.1001/jamaoncol.2018.1908 - DOI - PMC - PubMed